SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-167590
Filing Date
2006-08-09
Accepted
2006-08-09 15:25:47
Documents
15
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 733284
2 1999 STOCK OPTION PLAN dex101.htm EX-10.1 64886
3 1999 NONSTATUTORY STOCK OPTION PLAN dex102.htm EX-10.2 52481
4 1999 STOCK OPTION PLAN, AS AMENDED THROUGH FEBRUARY 20, 2003 dex103.htm EX-10.3 53133
5 FORM OF STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTIONS) dex104.htm EX-10.4 74452
6 FORM OF STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTIONS) dex105.htm EX-10.5 66115
7 FORM OF STOCK OPTION AGREEMENT UNDER THE 1999 NONSTATUTORY STOCK OPTION PLAN dex106.htm EX-10.6 66107
8 FORM OF NOTICE OF GRANT OF STOCK OPTION dex107.htm EX-10.7 13875
9 FORM OF STOCK OPTION AGREEMENT dex108.htm EX-10.8 58667
10 FORM OF NOTICE OF GRANT OF RESTRICTED STOCK AWARD dex109.htm EX-10.9 15508
11 FORM OF RESTRICTED STOCK AGREEMENT dex1010.htm EX-10.10 35631
12 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 5755
13 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 5834
14 CERTIFICATION BY THE CEO & CFO OF PDL BIOPHARMA, INC. dex321.htm EX-32.1 3306
15 GRAPHIC g59417image001.jpg GRAPHIC 12269
  Complete submission text file 0001193125-06-167590.txt   1267582
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 061017200
SIC: 2836 Biological Products, (No Diagnostic Substances)